These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37699718)

  • 21. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease.
    Pujadas L; Rossi D; Andrés R; Teixeira CM; Serra-Vidal B; Parcerisas A; Maldonado R; Giralt E; Carulla N; Soriano E
    Nat Commun; 2014 Mar; 5():3443. PubMed ID: 24599114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion.
    Pagnon de la Vega M; Syvänen S; Giedraitis V; Hooley M; Konstantinidis E; Meier SR; Rokka J; Eriksson J; Aguilar X; Spires-Jones TL; Lannfelt L; Nilsson LNG; Erlandsson A; Hultqvist G; Ingelsson M; Sehlin D
    Acta Neuropathol Commun; 2024 Feb; 12(1):22. PubMed ID: 38317196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
    Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
    Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice.
    Killick R; Scales G; Leroy K; Causevic M; Hooper C; Irvine EE; Choudhury AI; Drinkwater L; Kerr F; Al-Qassab H; Stephenson J; Yilmaz Z; Giese KP; Brion JP; Withers DJ; Lovestone S
    Biochem Biophys Res Commun; 2009 Aug; 386(1):257-62. PubMed ID: 19523444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
    Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
    PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S14G-humanin alleviates insulin resistance and increases autophagy in neurons of APP/PS1 transgenic mouse.
    Han K; Jia N; Zhong Y; Shang X
    J Cell Biochem; 2018 Apr; 119(4):3111-3117. PubMed ID: 29058763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion of Small GTPase H-Ras Rescues Memory Deficits and Reduces Amyloid Plaque-Associated Dendritic Spine Loss in Transgenic Alzheimer's Mice.
    Qu W; Jeong A; Zhong R; Thieschafer JS; Gram A; Li L
    Mol Neurobiol; 2023 Feb; 60(2):495-511. PubMed ID: 36287323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating Insulin-Like Growth Factor I is Involved in the Effect of High Fat Diet on Peripheral Amyloid β Clearance.
    Herrero-Labrador R; Trueba-Saiz A; Martinez-Rachadell L; Fernandez de Sevilla ME; Zegarra-Valdivia JA; Pignatelli J; Diaz-Pacheco S; Fernandez AM; Torres Aleman I
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-β in an APP transgenic mouse model.
    Liao F; Zhang TJ; Mahan TE; Jiang H; Holtzman DM
    Brain Behav Immun; 2015 Jul; 47():163-71. PubMed ID: 25218899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A
    Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X
    Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
    Crews L; Rockenstein E; Masliah E
    Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
    Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
    J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.